Phio Pharmaceuticals Corp...
(PHIO) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
1.82
-1.62%
Pre-market Jan 07, 2025, 04:03 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
Net Income | -10.83M | -11.48M | -13.29M | -8.79M | -8.91M | -7.36M | -12.45M | -8.99M | -10.22M | -8.80M | -20.93M | -12.88M | -10.22M |
Depreciation & Amortization | 184.00K | 193.00K | 75.00K | 72.00K | 67.00K | 81.00K | 70.00K | 53.00K | 77.00K | 87.00K | 99.00K | 147.00K | 163.00K |
Stock-Based Compensation | 303.00K | 414.00K | 480.00K | 136.00K | 300.00K | 282.00K | 314.00K | 756.00K | 1.53M | 1.85M | 1.98M | 968.00K | 2.11M |
Other Working Capital | -414.00K | -1.75M | 1.44M | -246.00K | -472.00K | -562.00K | 78.00K | 680.00K | 188.00K | -1.00M | 539.00K | 496.00K | 654.00K |
Other Non-Cash Items | 126.00K | 304.00K | 117.00K | 111.00K | 109.00K | 405.00K | 4.71M | -9.00K | 228.00K | -10.00K | 12.25M | 6.18M | -2.36M |
Deferred Income Tax | n/a | -304.00K | -233.00K | n/a | n/a | n/a | -1.62M | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -536.00K | -1.26M | 990.00K | -327.00K | -213.00K | -523.00K | -530.00K | 434.00K | 1.07M | -881.00K | 286.00K | 525.00K | 317.00K |
Operating Cash Flow | -10.75M | -12.13M | -11.86M | -8.80M | -8.64M | -7.52M | -9.51M | -7.76M | -7.32M | -7.76M | -6.31M | -5.06M | -9.99M |
Capital Expenditures | -5.00K | -121.00K | -51.00K | -19.00K | -72.00K | -5.00K | -203.00K | -4.00K | -57.00K | -95.00K | -78.00K | -15.00K | -59.00K |
Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 100.00K | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.00M | -8.00M | -5.00M | -9.00M | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.50M | 2.50M | 8.00M | 6.00M | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 100.00K | -150.00K | -5.50K | 12.00K | -15.00K | 31.00K | -53.00K |
Investing Cash Flow | -5.00K | -121.00K | -51.00K | -19.00K | -72.00K | -5.00K | -103.00K | 5.35M | -5.56M | 2.92M | -3.09M | 16.00K | -112.00K |
Debt Repayment | n/a | n/a | n/a | 204.00K | -6.00K | n/a | n/a | n/a | n/a | n/a | -5.00K | 471.00K | 383.00K |
Common Stock Repurchased | -13.00K | -28 | n/a | -15.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -209.00K | -4.13M | n/a | n/a | n/a |
Other Financial Acitivies | -39.00K | -26.00K | 2.15M | 3.85M | 69.00K | n/a | n/a | n/a | 9.70M | n/a | -7.00K | 17.70M | 3.33M |
Financial Cash Flow | 7.41M | -26.00K | 21.72M | 16.13M | 772.00K | 18.82M | 292.00K | 10.20M | 9.49M | 1.95M | 15.67M | 9.67M | 3.71M |
Net Cash Flow | -3.34M | -12.28M | 9.81M | 7.31M | -7.95M | 11.30M | -9.32M | 7.79M | -3.38M | -2.89M | 6.26M | 4.62M | -6.39M |
Free Cash Flow | -10.75M | -12.25M | -11.91M | -8.82M | -8.72M | -7.53M | -9.72M | -7.76M | -7.37M | -7.85M | -6.39M | -5.08M | -10.05M |